Alibaba (BABA) reported Q4 FY2026 earnings on May 13. The headline number, GAAP net profit up 106%, looked strong at first glance. One-time investment gains inflated it. Strip those out, and non-GAAP net income collapsed 99.7% to just 86 million yuan. The Stoxcraft data captured this before the report: every short and mid-term signal was already pointing down. The Q4 results confirmed what the scores were showing.
How BABA's Stoxcraft scores look after Q4 FY2026
What BABA's Performance Score of 2.6 is actually measuring
A Performance Score of 2.6 out of 10 places BABA in the bottom 40% of all 3,484 stocks in the Stoxcraft database. This is not a one-week reading. It reflects underperformance across every time horizon the score tracks: 1 month, 3 months, 1 year, 3 years, and 5 years simultaneously.
The 1Y return of +8.4% compares to a Consumer Cyclical sector average that is materially higher over the same period. The 5Y return of 38% below its starting point reflects a stock that has destroyed value in absolute terms while global equity markets compounded significantly.
This is the core issue. The business generates real cash. Operating cash flow per share of $8.11 is a strong number. But cash flow and price performance are two different things, and the score measures what the market has done with the business, not just what the business has done on its own.
The Q4 numbers that drove BABA's momentum decline
The Q4 earnings report brought the underlying deterioration into the open. GAAP net profit rose 106% to 25.5 billion yuan, a headline that triggered initial optimism. That number is inflated by one-time investment gains and does not reflect operating improvement.
The operating picture is different. Non-GAAP net income fell 99.7% to 86 million yuan. BABA recorded its first operating loss since 2021, at 848 million yuan negative. Adjusted EBITA dropped 84% to 5.1 billion yuan. These are the numbers that feed into momentum and trend signals.
Within the business, China e-commerce saw adjusted EBITA fall 40% to 24 billion yuan. The quick commerce buildout and intensifying competition with Meituan are compressing the core profit margin deliberately.
This is investment, not decay, but the score system registers declining margins regardless of intent. Cloud was the genuine standout: revenue up 38% year over year, with AI product revenue now accounting for 30% of external cloud revenue. Cloud growth alone cannot offset a 40% EBITA collapse in the segment that still drives the majority of group profit.
What BABA's Health Score of 6.9 means and why it is not enough
The Health Score of 6.9 out of 10 places BABA in the top 16% of the full universe and at rank #66 within Consumer Cyclical, which covers 411 stocks. The Piotroski Score of 8 out of 9 is a particularly strong fundamental reading. It reflects a company that scores positively on profitability, leverage, and operating efficiency across nearly every sub-metric. Net profit margin of 12.2% is above the sector median. The balance sheet carries substantial equity relative to debt.
This is why BABA is not a broken business story. A Health Score of 6.9 with a Piotroski of 8 says the underlying company is in good shape. What it does not say is that the market is rewarding that quality right now. The Risk Score of 5.4 adds one more data point: this is not a high-volatility, speculative name. The volatility here is geopolitical and structural, not operational. The beta of 0.49 means the stock moves at roughly half the market's daily amplitude.
This combination is what the data identifies as a Value Trap Warning: strong fundamentals, absent momentum.
Where BABA stands in Consumer Cyclical and what the entry signal says
BABA ranks #66 on Health within its 411-stock sector. That is genuinely strong. On total composite score it sits at #1,385 of 3,484 stocks overall, which is below average. Amazon (AMZN) ranks in the top 3 of the same sector with a Performance Score of 8.0 and a Health Score of 7.3. The gap on price performance is significant. Tencent (TCTZF) has maintained stronger short-term momentum through this cycle.
The entry signal reads Hold. Analyst consensus is pointing to $194.23 as a fair value price target, which is 45% above current levels. That is a substantial implied upside. The technical picture does not yet support acting on it. The trend direction is negative across all short-term timeframes.
RSI at 47.7 sits in neutral territory but is trending downward. MACD is negative. The entry model correctly flags that a large analyst upside target and a declining technical picture are in tension. The business may be worth significantly more. The scores say the price has not turned yet.
What needs to change before BABA's scores can recover
CEO Eddie Wu has signaled that the AI investment phase is shifting toward commercialization. Cloud growing at 38% with AI revenue at 30% of external cloud is a real data point, not just a narrative. If that trajectory continues into Q1 FY2027, and if e-commerce margins stabilize as the quick commerce buildout matures, the Performance Score has a path to recovery.
The sequence matters. The Health Score is already supporting the thesis. The Performance Score needs to turn first. That requires sustained price momentum over multiple consecutive weeks.
Once Performance moves above 5.0, the trend signal will follow. The overall rating upgrades last. Watch the Performance Score over the next 4 to 6 weeks. It is the leading indicator that will confirm whether the AI commercialization story is starting to price in.
